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ABSTRACT
Objectives: About 80% of world populations are still dependent on herbal plants. Rauwolfia is also one of the wonder drugs of India, which is used 
since ancient time. It contains a variety of compounds with antioxidant activity and other health benefits. A wild variety of rauwolfia is became 
endangered due to indiscriminate use. Hence, its cultivation and collection have been started to complete the demand of rauwolfia. Therefore, the 
study was designed to evaluate and compare the in vitro antioxidant and antidiabetic activity of the wild and cultivated plant of rauwolfia.
Methods: The methanolic extract of wild and cultivated plant was subjected to the DPPH and alpha-amylase inhibition activity for antioxidant and 
antidiabetic activity, respectively.
Result: The study revealed that the wild and cultivated variety of Rauwolfia serpentina does not have a significant difference in their antidiabetic and 
antioxidant activities. 
Conclusion: On the basis of the in-vitro studies, it can be concluded that cultivated variety of the plant can be used as a substitute for a wild variety 
of R. serpentina.
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INTRODUCTION
India has the oldest and richest diverse cultural tradition associated 
with the herbal medicinal plants for curing numerous ailments [1]. 
Almost, 80% of the world population is relying on herbal medicines 
for their health care benefits because plant-based treatments are 
safe, economic, accessible, reliable, and highly effective. Therefore, 
exponential growth in the overall demand for the herbal drugs and 
their products are reported globally. However, uncontrolled growth of 
the population and unplanned or excess use of plant species is making 
them endangered [2]. Approximately, 1/4th of all plant species in the 
world are at risk of being endangered or becoming extinct. Moreover, 
global warming and habitat destruction are also reasons of the 
disappearance of many plants. Some common plants which are become 
rare and endangered in the past 30 years due to habitat destruction are 
enlisted in Table 1.
In addition to this, there are some of the herbal plants which are used as 
substitute for the particular plants are Shatavari (Asparagus racemosus) 
is the substitution for Meda and Mahameda, Vidari (Pueraria tuberose) 
substitution for Jivaka and Rasabhaka, Ashvagandha (Withania 
somnifera) Kakoli and Ksirakakoli, Guduchi (Tinospora cordifolia), or 
Centaurea behen substitution for Jivaka, Orchis spp. which includes 
Munjataka (Orchis latifolia Linn.), Vamsha Rochana (Bambusa 
arundinaceae) or Salvia haematode substitution for Rasabhaka, 
Orchis mascula substitution for Meda, Gandhaprasarani (Paederia 
foetida), Musali (Sveta Musali) (Asparagus adscendens) substitution 
for Mahameda, Talamuli (Krishna Musali) (Curculigo orchioides) 
substitution for Kakoli, and Chlorophytum arundinaceum substitution 
for Ksirakakoli.
Other than these, Rauwolfia serpentina is one of the endangered 
plants. Although it also has a huge demand for its alkaloids, as well as 
the raw drug in the international market. The requirement of dried 
roots of rauwolfia is around 20,000 ton/year [3] across the globe.  It is 
commonly known as serpentina root, Indian snakeroot and belongs to 
the family Apocynaceae. It is a perennial glabrous herb or undershrub 
widely distributed in moist areas in subtropical Himalayas and plains 
from Punjab eastwards to Assam, Khasia Mountains, and Deccan 
Peninsula ascending to 1200 meters [4]. It has been used in India, 
since ancient time and reported in various texts of the indigenous 
system of medicine such as Ayurveda, Siddha, and Unani [5]. Dried 
roots of the plants are used for medicinal purpose and are mostly 
about 8–15 cm long and 0.5–2 cm in thickness subcylindrical curved 
and rarely branched. The outer surface is grayish yellow to brown 
with irregular longitudinal fissures. The fracture is short with slight 
odor and has bitter taste [6]. Rauwolfia serpentina is being used for 
the treatment of snakebites, mental illness, and blood pressure and it 
is highly reputed for hypertension, to treat painful affection of bowels, 
diarrhea, dysentery, cholera and colic, dyspepsia, epilepsy, giddiness, 
insomnia, and vitiated condition of kapha and vata [7,8]. It has been 
included in the Appendix II of “The Convention on International Trade 
in Endangered Species of Wild Fauna and Flora” (CITES) and in the 
negative list of exports plants by the Government of India (Notification 
no. 24 (RE- 98)/1977-2002) [9].
It became endangered with extinction in India, due to its indiscriminate 
collection, limited cultivation, and huge industrial demand. Hence, 
cultivation of rauwolfia has been started to complete the demand. 
However, a cultivated variety of rauwolfia is never evaluated and 
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compared for its therapeutic properties with wild variety. Hence, in the 
present study cultivated variety was evaluated and compared by in vitro 
antidiabetic and antioxidant activities.
METHODS
Sample collection
The roots of cultivated variety of the R. serpentina were collected from 
Herbal Garden and Herbarium Research Institute in ISM, Joginder 
Nagar, Himachal Pradesh. Whereas the wild variety was collected from 
the outskirts of Joginder Nagar, Himachal Pradesh.
Authentication
Samples of a wild and cultivated variety of R. serpentina were 
authenticated from Guru Nanak Dev University, Department of 
Botanical and Environmental Sciences, Amritsar (Punjab).
Preparation of methanolic extract
The coarse powder (40 g) of roots of R. serpentina was macerated with 
methanol (1 L; 95%) for 24 h (6 h frequent shaking and allowed to 
stand for 18 h). Then, the drug was filtered twice through Whatman 
filter paper no. 1. Then, methanol from the filtrate was evaporated by 
rotatory vacuum evaporator to get methanolic extracts of both samples.
Experimental procedures for in vitro studies
Antioxidant activity 
The 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay was 
performed with 700 µL of sample and MeOH (control) was added to the 
same volume of a methanolic solution of a 100 µM DPPH. Mixtures were 
shaken vigorously and left to stand in the dark at room temperature for 
20 min, and then, absorbance was read at 515 nm, using an ultraviolet 
spectrophotometer. Antioxidant activity was expressed as inhibition 
percentage (I%) and calculated using the following equation.






Alpha-amylase inhibition assay was performed using dinitrosalicylic acid 
(DNSA) coloring agent. A total of 500 µl of R. serpentina plant extract and 
500 µl of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M sodium 
chloride) containing α-amylase solution (0.5 mg/ml) and 500 µl of 1% 
starch solution in 0.02 M sodium phosphate buffer were incubated for 
10 min at 37°C. After incubation, 500 µl of sodium chloride was added 
to each tube at 5 s intervals, and then, 1 ml of DNSA color reagent was 
added to stop the reaction. These test tubes were then incubated in a 
boiling water bath for 5 min and cooled to room temperature. Finally, 
this reaction mixture was again diluted by adding 10 ml distilled water 
following which absorbance was measured at 540 nm.






Antioxidant DPPH activity 
Antioxidant activity was determined using DPPH assay at 0.1, 0.2, 
0.3, 0.4, and 0.5 µg/ml concentration of the methanolic extract of the 
R. serpentina plant. Ascorbic acid has been used as a standard drug 
for the determination of antioxidant potential of a wild and cultivated 
R. serpentina plants.
The results showed a percentage inhibition of 19, 27.5, 38, 47.9, and 
55 for cultivated and 34.99, 62.5, 76.09, 81.94, and 84.64 for wild at 
0.1, 0.2, 0.3, 0.4, and 0.5 µg/ml concentrations, respectively (Table 2). A 
comparative DPPH % inhibition is plotted in Fig. 1 for wild, cultivated, 
and ascorbic acid. The IC50 calculated for wild variety is 0.20 µg/ml 
and cultivated is 0.42 µg/ml, respectively. Hence, a wild variety of the 
plant showed good antioxidant activity compared to the cultivated 
R. serpentine and comparable to ascorbic acid.
Table 1: Endangered plants in India
S. No. Region Botanical name Common name Status* 
1 Arunachal Pradesh Amentotaxus assamica Assam catkin yew T
2 Gujarat Polygala irregularis Milkwort R
3 Gujarat Lotus corniculatus Bird’s foot R
4 Gujarat Ceropegia odorata Jeemikanda E
5 Himachal Pradesh Colchicum luteum Colchicicum R, T
6 Jammu Nymphaea tetragona White Water-lily E 
7 Kashmir Nymphaea tetragona White Water-lily T
8 Karnataka Psilotum nudum Fork fern R
9 Karnataka Diospyros celibica Ebony tree T
10 Kerala Actinodaphne lawsonii - T
11 Kerala Pterospermum reticulatum Malayuram R 
12 Madhya Pradesh Belosynapsis vivipara - R, E
13 Rajasthan Ceropegia odorata Jeemikanda E
14 Tamil Nadu Pterospermum reticulatum Malayuram T
15 Tamil Nadu Acacia planifrons Umbrella tree R
16 Tamil Nadu Abutilon indicum Atibala R
17 Tamil Nadu Chlorophytum malabaricum Malabar lily T
*(T: Threatened, R: Rare, E: Endangered)
Table 2: DPPH assay
S. No. Concentration (µg/ml) Inhibition (%)
Wild Cultivated Ascorbic 
acid
1 0.1 34.99 19.00 45.56
2 0.2 62.5 27.50 52
3 0.3 76.09 38.00 62
4 0.4 81.94 47.9 73.65
5 0.5 84.64 55.00 95.34
DPPH: 1,1-diphenyl-2-picrylhydrazyl
Table 3: α-amylase assay
S. No. Concentration (µg/ml) Inhibition (%)
Wild Cultivated Acarbose
1 0.1 16.68 13.70 8.1
2 0.2 21.79 18.73 25.54
3 0.3 24.32 20.11 50.43
4 0.4 26.30 25.43 63.23
5 0.5 58.43 51.80 87.71
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Antidiabetic activity
There was a dose-dependent increase in percentage inhibitory activity 
against α-amylase enzyme. The extract at a concentration 0.1, 0.2, 
0.3, 0.4, and 1.0 µg/ml showed a percentage inhibition of 13.7, 18.73, 
20.11, 25.43, and 51.80 for cultivated and 16.68, 21.79, 24.32, 26.30, 
and 58.43 for wild, respectively (Table 3). A comparative alpha-amylase 
% inhibition is plotted in Fig. 2 for wild, cultivated, and acarbose 
(a standard drug). The wild variety of the plant shows more inhibition 
as compared to the cultivated R. serpentina. The IC50 calculated for wild 
variety is 0.83 µg/ml and cultivated is 0.96 µg/ml, respectively. 
CONCLUSION
Plants serve as an excellent source of various therapeutic agents. One 
of the major advantages of using plants is that they do not show the 
deleterious side effects commonly associated with other drugs. This 
research work explored the antioxidant as well as the antidiabetic 
activity of the wild and cultivated variety of R. serpentina plant. The 
study suggested that the wild source of the plant has more potential 
to exert antioxidant and antidiabetic activity as compared to the 
cultivated plant. Although the wild variety of R. serpentina plant is 
more promising, results showed that it can be substituted with 
cultivated variety for antioxidant and antidiabetic activity in case of 
need.
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Fig. 1: 1,1-diphenyl-2-picrylhydrazyl inhibitory % age of the wild 
and cultivated plant extracts
Fig. 2: Alpha-amylase inhibitory % age of the wild and cultivated 
plant extracts
